Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

METORTRIT™ injection solution 10mg/ml (1.75ml), syringes 1pc

🔥 4 items sold in last 3 hours
22 people are viewing this product
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 6
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 8
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 10
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 12
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 14
Brand:
Active Ingredient:

Manufacturer:

$62.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

METORTRIT™ injection solution 10mg/ml (1ml), syringe 1pc

$64.00
Add to cart

METORTRIT™ injection solution 10mg/ml (1.25ml), syringe 1pc

$60.00
Add to cart

Analogs of METORTRIT™

METOJECT™ solution for subcutaneous injection 50mg/ml (0.25ml), syringes 1pc

$50.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.35ml), syringes 1pc

$73.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.4ml), syringes 1pc

$70.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.5ml), syringes 1pc

$86.00
Add to cart

Table of Contents

METORTRIT™ 10mg Solution 1.75ml Buy Online

METORTRIT Injection Solution: A Comprehensive Overview

Managing chronic inflammatory conditions can be challenging, but advancements in medicine offer effective solutions. METORTRIT injection solution provides a targeted approach to managing these conditions, offering relief and improved quality of life for many patients. This overview delves into its key aspects and considerations.

METORTRIT, a sterile injectable solution, is a powerful tool in the treatment of various autoimmune and inflammatory diseases. Its precise mechanism of action and versatile administration methods contribute to its efficacy and adaptability in diverse clinical settings. Understanding its properties and potential benefits is crucial for both healthcare professionals and patients.

The 10mg/ml concentration, packaged in convenient single-use syringes, simplifies administration and enhances patient convenience. This precise dosage allows for accurate and effective treatment, minimizing the risk of medication errors and promoting optimal therapeutic outcomes. The formulation ensures consistent drug delivery and efficacy, crucial for managing chronic conditions.

This injectable formulation is meticulously designed for ease of use while maintaining the high standards of sterility and precision necessary for parenteral administration. Each aspect, from the concentration to the packaging, contributes to the overall efficacy and safety of the treatment.

Understanding METORTRIT

METORTRIT injection solution is a powerful medication containing methotrexate, a disease-modifying antirheumatic drug (DMARD). It’s primarily used to treat various inflammatory conditions, acting as both an anti-inflammatory and immunosuppressant agent. Its mechanism involves interfering with the body’s immune response, reducing the inflammation and pain associated with these conditions.

Methotrexate’s mode of action centers on its ability to inhibit dihydrofolate reductase, a crucial enzyme in the synthesis of DNA and RNA. By disrupting these processes, methotrexate effectively slows the rapid cell growth characteristic of many inflammatory diseases. This targeted approach helps to mitigate symptoms and, in some cases, to promote disease remission.

The 10mg/ml concentration ensures precise dosing, crucial for managing the delicate balance of therapeutic efficacy and minimizing adverse effects. Individualized dosing regimens, tailored to the specific condition and patient response, are essential for optimal results. Careful monitoring by a healthcare professional is vital throughout the treatment course.

Understanding the unique properties of METORTRIT, including its mechanism of action and dosage considerations, is paramount for both patients and physicians. This knowledge allows for informed decision-making, leading to successful treatment outcomes and improved patient well-being. The medication’s ability to effectively target the underlying inflammatory processes makes it a valuable tool in managing these challenging conditions.

Therapeutic Applications of METORTRIT

METORTRIT’s therapeutic versatility extends to a range of debilitating autoimmune and inflammatory diseases. Its efficacy in managing these conditions stems from its unique ability to modulate the immune system and reduce inflammation, bringing significant relief to patients. This section explores key applications where METORTRIT demonstrates notable clinical benefits.

Rheumatoid arthritis (RA), a chronic inflammatory disorder affecting the joints, is a primary target for METORTRIT treatment. By suppressing the immune response that contributes to joint inflammation and pain, METORTRIT helps improve mobility and reduce the debilitating effects of RA. Many patients experience significant symptom relief, improving their overall quality of life.

In juvenile idiopathic arthritis (JIA), a chronic inflammatory condition affecting children, METORTRIT offers a crucial therapeutic option. It effectively manages the inflammation and pain in affected joints, helping children maintain their mobility and participate in daily activities. Careful monitoring and dose adjustments are essential in pediatric applications.

Psoriasis and psoriatic arthritis, characterized by skin inflammation and joint pain respectively, are also effectively managed with METORTRIT. Its ability to suppress immune system activity helps alleviate the skin lesions and joint inflammation associated with these conditions. The medication can significantly reduce the severity of symptoms, improving both physical and mental well-being.

The broad applicability of METORTRIT underscores its crucial role in managing a wide spectrum of inflammatory diseases. Its efficacy across various conditions, coupled with its precise dosing and convenient administration, makes it a valuable asset in modern rheumatology and dermatology practices. The drug’s impact on patient lives is profound, offering a chance at improved mobility, reduced pain, and enhanced quality of life.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease causing significant joint pain, swelling, and stiffness. The underlying inflammation is driven by an overactive immune system, targeting the joints and causing progressive damage. METORTRIT plays a crucial role in managing this debilitating condition.

In RA treatment, METORTRIT acts as a disease-modifying antirheumatic drug (DMARD). Unlike simple pain relievers, DMARDs target the underlying cause of the inflammation, slowing disease progression and preventing long-term joint damage. This approach offers substantial benefits compared to solely managing symptoms.

The injectable formulation of METORTRIT allows for consistent drug delivery, optimizing therapeutic efficacy. Regular administration, as prescribed by a physician, is crucial for maintaining symptom control and preventing disease flares. Individualized treatment plans are tailored to each patient’s needs and response.

For patients with moderate to severe RA who haven’t responded well to other treatments, METORTRIT offers a significant chance for improved joint health and reduced pain. By addressing the root cause of inflammation, METORTRIT improves mobility, functionality, and overall quality of life for individuals struggling with this chronic disease. Close monitoring of potential side effects is essential.

Juvenile Idiopathic Arthritis

Juvenile idiopathic arthritis (JIA) presents unique challenges, affecting children with chronic joint inflammation and pain. The impact on a child’s development, mobility, and overall well-being can be profound. METORTRIT offers a targeted approach to managing this complex condition.

In pediatric rheumatology, METORTRIT’s role is to suppress the underlying immune response driving the inflammation in JIA. Its efficacy in reducing joint swelling, pain, and stiffness allows children to maintain a higher level of activity and participate more fully in their daily lives. Careful monitoring of growth and development is crucial.

The precise dosing of METORTRIT, available in convenient single-use syringes, simplifies administration for both healthcare providers and caregivers. This precision is vital in pediatric patients, where accurate dosing is paramount for optimizing efficacy and minimizing potential side effects. Regular monitoring by a specialist is essential.

While not a cure, METORTRIT’s ability to effectively control the inflammatory processes in JIA significantly improves a child’s quality of life. By reducing pain and stiffness, METORTRIT fosters greater independence and allows children to engage in age-appropriate activities. This contributes positively to their physical, emotional, and social development. Long-term management often involves ongoing monitoring and adjustments to the treatment plan.

Psoriasis and Psoriatic Arthritis

Psoriasis and psoriatic arthritis are chronic inflammatory conditions affecting the skin and joints, respectively. Psoriasis manifests as raised, red, scaly patches on the skin, while psoriatic arthritis causes joint pain, swelling, and stiffness. METORTRIT offers a significant therapeutic benefit in managing both.

In psoriasis, METORTRIT’s immunomodulatory effects help to reduce the overactive immune response contributing to skin inflammation. By suppressing the production of inflammatory cytokines, METORTRIT helps clear skin lesions and improve the appearance of psoriatic plaques. This can significantly improve a patient’s self-esteem and quality of life.

For patients with psoriatic arthritis, METORTRIT effectively targets the underlying joint inflammation. Its ability to reduce joint pain, swelling, and stiffness improves mobility and daily functionality. This targeted approach addresses both the skin and joint manifestations of the disease, providing comprehensive symptom relief.

The convenient, single-use syringe format of METORTRIT simplifies self-administration for patients managing these chronic conditions. Regular injections, as directed by a healthcare professional, are vital for maintaining symptom control and preventing disease flares. The medication’s impact on both skin and joint symptoms enhances overall patient well-being, reducing the debilitating effects of these inflammatory conditions. Careful monitoring of potential side effects remains essential.

Mechanism of Action

METORTRIT’s therapeutic effects stem from its active ingredient, methotrexate, a folate antagonist. This means it interferes with the metabolic pathway involving folic acid, a crucial component in DNA and RNA synthesis. By inhibiting dihydrofolate reductase, a key enzyme in this pathway, methotrexate disrupts cellular replication.

This disruption of cellular processes is particularly effective against rapidly dividing cells, such as those involved in inflammatory responses. In autoimmune diseases, the immune system mistakenly attacks healthy tissues, leading to inflammation. Methotrexate’s action helps to dampen this overactive immune response.

Beyond its effects on rapidly dividing cells, methotrexate also possesses anti-inflammatory properties. It modulates the production of various inflammatory cytokines, reducing the overall inflammatory cascade that contributes to the symptoms of autoimmune diseases. This dual mechanism contributes to METORTRIT’s efficacy.

The precise mechanism by which methotrexate exerts its anti-inflammatory effects is still under investigation, but it’s believed to involve interactions with multiple cellular pathways. This complex interplay contributes to its effectiveness in managing a range of inflammatory conditions, offering significant relief to patients. Understanding this intricate mechanism is crucial for appreciating METORTRIT’s therapeutic potential.

Administration and Dosage

METORTRIT’s administration is via subcutaneous injection, offering a convenient and relatively painless method of drug delivery. The pre-filled syringes ensure accurate dosing and ease of use, minimizing the risk of medication errors. This method allows for consistent drug absorption and reliable therapeutic effects.

Dosage regimens for METORTRIT are highly individualized, tailored to the specific condition being treated and the patient’s response. Factors such as disease severity, overall health, and potential drug interactions are carefully considered when determining the appropriate dosage. A healthcare professional will establish and monitor the treatment plan.

Initial doses are typically low, gradually increasing over time based on clinical response and tolerance. Regular monitoring of blood counts and liver function is crucial to detect any potential adverse effects. Adjustments to dosage may be necessary depending on the patient’s response and the presence of any side effects.

The 10mg/ml concentration, presented in 1.75ml syringes, facilitates precise dosing and accurate administration. This ensures that patients receive the optimal therapeutic benefit while minimizing the risk of adverse events. Adherence to the prescribed dosage and schedule is critical for achieving the desired therapeutic outcome and maintaining overall health.

Pros of Using METORTRIT

METORTRIT offers several key advantages in managing chronic inflammatory conditions. Its effectiveness in reducing inflammation and pain provides significant relief for patients, improving their overall quality of life. This translates to greater mobility, increased functionality, and enhanced well-being.

The convenient single-use syringe simplifies administration, making the treatment process easier for both patients and healthcare providers. This ease of use promotes better adherence to the prescribed treatment regimen, contributing to improved therapeutic outcomes. The precise dosing further enhances the benefits.

METORTRIT’s ability to target the underlying inflammatory processes, rather than just masking symptoms, offers long-term benefits. By modulating the immune response, it helps to prevent disease progression and reduce the risk of long-term joint damage. This disease-modifying effect is a critical advantage.

The versatility of METORTRIT, applicable to various conditions like rheumatoid arthritis, juvenile idiopathic arthritis, psoriasis, and psoriatic arthritis, makes it a valuable therapeutic option across a range of inflammatory diseases. This broad applicability, combined with its convenient administration, makes it a powerful tool in managing these challenging conditions. Improved patient outcomes and a better quality of life are key benefits.

Cons of Using METORTRIT

While METORTRIT offers significant therapeutic benefits, it’s crucial to acknowledge potential drawbacks. Like many medications, it carries the risk of adverse effects, varying in severity and frequency among individuals. Careful monitoring by a healthcare professional is essential throughout the treatment.

Gastrointestinal issues, such as nausea, vomiting, and abdominal pain, are commonly reported side effects. These are often manageable with appropriate supportive care and may lessen over time as the body adjusts to the medication. Adjustments to dosage or timing of administration may be necessary.

Liver function abnormalities are another potential concern. Regular monitoring of liver enzymes is therefore recommended to detect any significant changes. In cases of elevated liver enzymes, adjustments to the dosage or even temporary discontinuation of the medication may be required. Prompt medical attention is crucial.

The potential for immunosuppression, while beneficial in managing autoimmune diseases, also increases the risk of infections. Patients should be vigilant about any signs of infection and report them immediately to their healthcare provider. Preventive measures, such as vaccinations and avoiding close contact with sick individuals, are recommended. Careful monitoring and proactive management are essential to mitigate these risks.

Conclusion

METORTRIT injection solution represents a significant advancement in the management of various chronic inflammatory conditions. Its targeted mechanism of action, combined with convenient administration, offers substantial benefits for patients. The ability to effectively manage symptoms and potentially slow disease progression significantly improves quality of life.

While potential side effects must be carefully considered and monitored, the overall therapeutic advantages of METORTRIT are substantial. The drug’s efficacy in reducing inflammation and pain, coupled with its versatility across different conditions, makes it a valuable asset in modern medical practice. Individualized treatment plans, tailored to patient needs and monitored by healthcare professionals, are crucial for maximizing benefits and minimizing risks.

The information presented here provides a comprehensive overview, highlighting both the positive and negative aspects of METORTRIT. This understanding empowers patients and healthcare providers to make informed decisions, leading to successful treatment outcomes and improved patient well-being. Remember that this information is for educational purposes only and should not substitute for professional medical advice.

Ultimately, METORTRIT offers a powerful tool for managing the debilitating effects of chronic inflammatory diseases. Its targeted approach, coupled with careful monitoring and individualized treatment plans, positions it as a valuable option for patients seeking relief and improved quality of life. Always consult with your healthcare provider for personalized guidance and to address any specific questions or concerns.

  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 16
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 18
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (1.75Ml), Syringes 1Pc Buy Online 20
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “METORTRIT™ injection solution 10mg/ml (1.75ml), syringes 1pc”

Your email address will not be published. Required fields are marked

Similar products

LESTRODEX™ tablets 2.5mg, 30pcs

$134.00
Add to cart

CAPECITABINE tablets 500mg, 120pcs

$530.00
Add to cart

CABOMETYX™ tablets 40mg, 30pcs

$25,072.00
Add to cart

CABOMETYX™ tablets 60mg, 30pcs

$25,072.00
Add to cart

IMBRUVICA™ capsules 140mg, 90pcs

$28,002.00
Add to cart

IMFINZI™ concentrate for infusion solution 50mg/ml (10ml), vial 1pc

$10,270.00
Add to cart

IMATINIB tablets 100mg, 30pcs

$163.00
Add to cart

ZOLADEX™ implant 10.8mg, syringe applicators 1pc

$854.00
Add to cart

ZOLADEX™ implant 3.6mg, syringe applicators 1pc

$253.00
Add to cart

ZARSIO™ solution for IV and SC injection 48 million IU/0.5ml (0.5ml), syringes 5pcs

$1,273.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (2ml), vial 1pc

$150.00
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 440mg + solvent 20ml, vial 1pc

$1,945.00
Add to cart

HYDREA™ capsules 500mg, 20pcs

$16.00
Add to cart

HEMANGIOL™ oral solution 3.75mg/ml (120ml), vial 1pc

$1,143.00
Add to cart

VINBLASTIN-LENS™ lyophilisate for IV infusion 5mg, vial 1pc

$27.00
Add to cart

BLINCYTO™ lyophilisate for concentrate for infusion solution 35mcg+stabilizer, vial 1pc

$11,119.00
Add to cart

BICALUTAMIDE tablets 150mg, 30pcs

$151.00
Add to cart

BICALUTAMIDE tablets 50mg, 30pcs

$77.00
Add to cart

BARTIZAR™ lyophilisate for IV/SC injection 3.5mg, 1pc

$934.00
Add to cart

BAVENCIO™ concentrate for infusion solution 20mg/ml (10ml), vial 1pc

$3,690.00
Add to cart

ARFLEIDA™ concentrate for infusion solution 25mg/ml (4ml), 1 vial

$7,437.00
Add to cart

ANASTROZOLE tablets 1mg, 30pcs

$80.00
Add to cart

ANAZALES™ tablets 1mg, 28pcs

$73.00
Add to cart

AVASTIN™ concentrate for infusion solution 25mg/ml (400mg/16ml), vial 16ml 1pc

$2,272.00
Add to cart
Select your currency